2018 International Congress Archives - Page 26 of 177

Botulinum toxin in Essential Hand Tremor – A Randomized Double-Blind Placebo-Controlled study with Customized Injection Approach

S. Mittal, D. Machado, D. Richardson, D. Dubey, B. Jabbari (Bangalore, India)
Botulinum toxin in Restless Leg Syndrome – A Randomized Double-Blind Placebo-Controlled Study

S. Mittal, D. Machado, D. RIchardson, D. Dubey, B. Jabbari (Bangalore, India)
Botulinum toxin injection for Pisa syndrome in Parkinson’s disease

CA. Artusi, M. Zibetti, P. Barbero, M. Busso, S. Bortolani, S. De Mercanti, P. Arnoffi, M. Fabbri, A. Merola, L. Lopiano (Torino, Italy)
Botulinum toxin injections improve daily life activities in patients with upper limb tremor

A. Kreisler, B. Bouchain, L. Defebvre (Lille, France)
Botulinum Toxin Injections in Upper Limb Tremor

W. Fung, M. Ligtermoet, K. Bertram, D. Williams, J. Kamel (Melbourne, Australia)
Bradykinesia assessment using evolutionary algorithms in Parkinson’s disease: Clinical validation

C. Gao, S. Smith, M. Lones, S. Jamieson, J. Alty, J. Cosgrove, P. Zhang, J. Liu, Y. Chen, J. Du, S. Cui, H. Zhou, S. Chen (Shanghai, China)
Brain Mechanisms of Associative Memory Deficits in Parkinson’s Disease without Dementia

T. Alrazi, J. Cheetham, L. Derwent, A. Hanganu, T. Hammer, I. Kathol, M. Kibreab, S. Lang, N. Ouellet, J. Provost, M. Ramezani, J. Sarna, E. Yoon, O. Monchi (Calgary, AB, Canada)
Brain network activation (BNA): A new biomarker for Parkinson’s disease?

S. Hassin-Baer, Z. Pereman, R. Yahav, S. Israeli-Korn, G. Yahalom, S. Benizri, R. Shani-Hershkovich, G. Issachar, A. Geva, O. Cohen (Ramat Gan, Israel)
Brain Network Connectivity Measured by Diffusion Tensor Imaging Predicts Prognosis in Parkinson’s Disease

S.M. Fereshtehnejad, N. Abbasi, Y. Zeighami, K. Larcher, R. Postuma, A. Dagher (Montreal, QC, Canada)
Brain Perfusion pattern linked to depressive state in Parkinson’s: An arterial spin labelling MRI study

Y. Xing, S. Naidu, S. Schwarz, N. Bajaj, D. Auer (Nottingham, United Kingdom)